KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Aurinia Pharmaceuticals (AUPH) Shares Issued: 2014-2025

Historic Shares Issued for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Sep 2025 value amounting to $2.0 million.

  • Aurinia Pharmaceuticals' Shares Issued rose 394.54% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year increase of 79.43%. This contributed to the annual value of $8.2 million for FY2024, which is 53.76% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Shares Issued stood at $2.0 million, which was up 53.07% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Shares Issued peaked at $181.4 million during Q4 2021, and registered a low of $167,000 during Q4 2022.
  • Moreover, its 3-year median value for Shares Issued was $1.4 million (2023), whereas its average is $2.4 million.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Shares Issued crashed by 99.91% in 2022, and later soared by 735.33% in 2023.
  • Quarterly analysis of 5 years shows Aurinia Pharmaceuticals' Shares Issued stood at $181.4 million in 2021, then slumped by 99.91% to $167,000 in 2022, then surged by 735.33% to $1.4 million in 2023, then rose by 18.21% to $1.6 million in 2024, then skyrocketed by 394.54% to $2.0 million in 2025.
  • Its Shares Issued was $2.0 million in Q3 2025, compared to $1.3 million in Q2 2025 and $9.3 million in Q1 2025.